Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C B Hyman

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Annals of the New York Academy of Sciences|January 1, 1980
The clinical significance of magnesium depletion in thalassemiaC B Hyman, J A Ortega, G Costin, et al.
Blood|June 1, 1971
Congenital familial megaloblastic anemiaB C Lampkin, A Pyesmany, C B Hyman, et al.
American Journal of Diseases of Children (1960)|May 1, 1979
Endocrine abnormalities in thalassemia majorG Costin, M D Kogut, C B Hyman, et al.
Annals of the New York Academy of Sciences|January 1, 1985
Combined subcutaneous and high-dose intravenous deferoxamine therapy of thalassemiaC B Hyman, C L Agness, R Rodriguez-Funes, et al.
Perspectives in Pediatric Pathology|January 1, 1987
Pulmonary lesions of thalassemia majorB H Landing, R Nadorra, C B Hyman, et al.
The American Journal of Pediatric Hematology/Oncology|January 1, 1989
Mineral balance (iron, aluminum, copper, zinc) after high-dose intravenous Desferal in a child with hemoglobin Hammersmith and Turner's syndromeC B Hyman, H C Gonick, N Neufeld, et al.
Birth Defects Original Article Series|January 1, 1988
Effects of deferoxamine on renal function in thalassemiaC B Hyman, H C Gonick, C Agness, et al.
Skeletal Radiology|January 1, 1992
Case report 744. Deferoxamine-induced skeletal dysplasiaZ C Borenstein, C B Hyman, D L Rimoin, et al.
Annals of the New York Academy of Sciences|January 1, 1974
Dl-alpha-tocopherol, iron, and lipofuscin in thalassemiaC B Hyman, B Landing, R Alfin-Slater, et al.
Pediatrics|May 1, 1980
Pulmonary function abnormalities in thalassemia patients on a hypertransfusion programT G Keens, M H O'Neal, J A Ortega, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Annals of the New York Academy of Sciences|January 1, 1980
The clinical significance of magnesium depletion in thalassemiaC B Hyman, J A Ortega, G Costin, et al.
Blood|June 1, 1971
Congenital familial megaloblastic anemiaB C Lampkin, A Pyesmany, C B Hyman, et al.
American Journal of Diseases of Children (1960)|May 1, 1979
Endocrine abnormalities in thalassemia majorG Costin, M D Kogut, C B Hyman, et al.
Annals of the New York Academy of Sciences|January 1, 1985
Combined subcutaneous and high-dose intravenous deferoxamine therapy of thalassemiaC B Hyman, C L Agness, R Rodriguez-Funes, et al.
Perspectives in Pediatric Pathology|January 1, 1987
Pulmonary lesions of thalassemia majorB H Landing, R Nadorra, C B Hyman, et al.
The American Journal of Pediatric Hematology/Oncology|January 1, 1989
Mineral balance (iron, aluminum, copper, zinc) after high-dose intravenous Desferal in a child with hemoglobin Hammersmith and Turner's syndromeC B Hyman, H C Gonick, N Neufeld, et al.
Birth Defects Original Article Series|January 1, 1988
Effects of deferoxamine on renal function in thalassemiaC B Hyman, H C Gonick, C Agness, et al.
Skeletal Radiology|January 1, 1992
Case report 744. Deferoxamine-induced skeletal dysplasiaZ C Borenstein, C B Hyman, D L Rimoin, et al.
Annals of the New York Academy of Sciences|January 1, 1974
Dl-alpha-tocopherol, iron, and lipofuscin in thalassemiaC B Hyman, B Landing, R Alfin-Slater, et al.
Pediatrics|May 1, 1980
Pulmonary function abnormalities in thalassemia patients on a hypertransfusion programT G Keens, M H O'Neal, J A Ortega, et al.
Pageof 2